Dan Vega

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Anaptysbio, Inc publishes a filing, an earnings call transcript or a press release.

Get ANAB alerts

About Dan Vega

Dan Vega is recorded as CEO at Anaptysbio, Inc (ANAB). Dan Vega has spoken on 2 investor events across 1 company, most recently for Anaptysbio, Inc on March 10, 2026. Anaptysbio, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anaptysbio, Inc includes Daniel Faga (CEO and Board Member), John Orwin (Chairman and Board Member), Ajim Tamboli (CFO) and 7 others.

Dan Vega on recent calls

“We're approximately a month or two out from creating a second company called First Tracks Bio. which will be the biopharma operations for Monaptis that we're spitting off.”

CEO, Barclays 28th Annual Global Healthcare Conference · March 10, 2026

“This presentation contains forward-looking statements. Please refer to our SEC filings for further details. For the past 20 years, Anaptis has been known for generating best-in-class antibodies.”

CEO, Strategic Separation to Maximize Shareholder Value · September 29, 2025